fda drug shortage list semaglutide status january 2025 GLP-1 No Longer on FDA's GLP-1 Shortage = Over -

In summary, diabetes significantly impacts sexual function, and patients should prioritize comprehensive diabetes management to actively prevent and treat sexual dysfunction, thereby improving overall quality of life

In 2026, many states permit asynchronous reviews, which means you might not need to have a video review if your health history is uncomplicated

Never skip meals or fast before drinking while on GLP-1 therapy, as this amplifies dehydration and GI distress

Appetite drops noticeably within 12 weeks

Nonetheless, the activation of this receptor with FFAs has demonstrated to induce the secretion of incretins (79, 258) glucagon (78, 250) and partially glucose-stimulated insulin (259, 260) reducing food intake, and lowering body weight in animals models (261)

The FDA has approved the following GLP-1 medications for heart health